News/ News/ R&D BioMarin seeks haemophilia gene therapy approval after promising data George Underwood BioMarin, gene therapy, haemophilia, valoctocogene roxaparvovec 0 Comment BioMarin is set to file for approval for its haemophilia gene therapy valoctocogene roxaparvovec, after it achieved pre-specified Share X BioMarin seeks haemophilia gene therapy approval after promising data https://pharmaphorum.com/news/biomarin-seeks-haemophilia-gene-therapy-approval-after-promising-data/